当前位置: X-MOL 学术Biomol. Biomed. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
miR-212-3p attenuates neuroinflammation of rats with Alzheimer's disease via regulating the SP1/BACE1/NLRP3/Caspase-1 signaling pathway.
Biomolecules and Biomedicine ( IF 3.1 ) Pub Date : 2022-07-29 , DOI: 10.17305/bjbms.2021.6723
Wei Nong 1 , Chuanhong Bao 1 , Yixin Chen 1 , Zhiquan Wei 1
Affiliation  

Alzheimer's disease (AD) ranks as the leading cause of dementia. MicroRNA (miR)-212-3p has been identified to exert neuroprotective effects on brain disorders. The current study analyzed the protective role of miR-212-3p in AD rats via regulating the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3)/Caspase-1 signaling pathway. The AD rat model was established via injection of amyloid-β 1-42 (Aβ1-42), followed by the Morris water maze test. The morphology and functions of neurons were observed. Furthermore, miR-212-3p, NLRP3, cleaved Caspase-1, gasdermin D N-terminus, interleukin (IL)-1β and IL-18 expressions were measured. H19-7 cells were treated with Aβ1-42 to establish the AD cell model, followed by an assessment of cell viability and pyroptosis. Downstream targets of miR-212-3p and specificity protein 1 (SP1), as well as beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) were predicted by databases and testified using dual-luciferase and chromatin immunoprecipitation assays. miR-212-3p was weakly expressed in AD rats. miR-212-3p overexpression was linked to improved learning and memory capacities of AD rats and reduced neuronal pyroptosis linked to neuroinflammation attenuation. In vitro, miR-212-3p improved viability and suppressed pyroptosis of neurons via inhibiting NLRP3/Caspase-1. Overall, miR-212-3p inhibited SP1 expression to block BACE1-induced activation of NLRP3/Caspase-1, thereby attenuating neuroinflammation of AD rats.

中文翻译:

miR-212-3p 通过调节 SP1/BACE1/NLRP3/Caspase-1 信号通路减轻阿尔茨海默病大鼠的神经炎症。

阿尔茨海默病 (AD) 是导致痴呆的主要原因。已确定 MicroRNA (miR)-212-3p 对脑部疾病发挥神经保护作用。本研究分析了miR-212-3p通过调控核苷酸结合寡聚结构域样受体家族pyrin结构域3(NLRP3)/Caspase-1信号通路对AD大鼠的保护作用。通过注射淀粉样蛋白-β1-42(Aβ1-42)建立AD大鼠模型,然后进行Morris水迷宫试验。观察神经元的形态和功能。此外,测量了 miR-212-3p、NLRP3、切割的 Caspase-1、gasdermin D N 末端、白细胞介素 (IL)-1β 和 IL-18 的表达。用 Aβ1-42 处理 H19-7 细胞以建立 AD 细胞模型,然后评估细胞活力和细胞焦亡。数据库预测了 miR-212-3p 和特异性蛋白 1 (SP1) 以及 β 位点淀粉样前体蛋白裂解酶 1 (BACE1) 的下游靶标,并使用双荧光素酶和染色质免疫沉淀测定法进行了验证。miR-212-3p 在 AD 大鼠中表达较弱。miR-212-3p 过表达与改善 AD 大鼠的学习和记忆能力有关,并减少与神经炎症减弱有关的神经元焦亡。在体外,miR-212-3p 通过抑制 NLRP3/Caspase-1 提高了神经元的活力并抑制了细胞焦亡。总体而言,miR-212-3p 抑制 SP1 表达以阻断 BACE1 诱导的 NLRP3/Caspase-1 激活,从而减轻 AD 大鼠的神经炎症。以及 β 位点淀粉样前体蛋白裂解酶 1 (BACE1) 由数据库预测,并使用双荧光素酶和染色质免疫沉淀测定法进行验证。miR-212-3p 在 AD 大鼠中表达较弱。miR-212-3p 过表达与改善 AD 大鼠的学习和记忆能力有关,并减少与神经炎症减弱有关的神经元焦亡。在体外,miR-212-3p 通过抑制 NLRP3/Caspase-1 提高了神经元的活力并抑制了细胞焦亡。总体而言,miR-212-3p 抑制 SP1 表达以阻断 BACE1 诱导的 NLRP3/Caspase-1 激活,从而减轻 AD 大鼠的神经炎症。以及 β 位点淀粉样前体蛋白裂解酶 1 (BACE1) 由数据库预测,并使用双荧光素酶和染色质免疫沉淀测定法进行验证。miR-212-3p 在 AD 大鼠中表达较弱。miR-212-3p 过表达与改善 AD 大鼠的学习和记忆能力有关,并减少与神经炎症减弱有关的神经元焦亡。在体外,miR-212-3p 通过抑制 NLRP3/Caspase-1 提高了神经元的活力并抑制了细胞焦亡。总体而言,miR-212-3p 抑制 SP1 表达以阻断 BACE1 诱导的 NLRP3/Caspase-1 激活,从而减轻 AD 大鼠的神经炎症。miR-212-3p 过表达与改善 AD 大鼠的学习和记忆能力有关,并减少与神经炎症减弱有关的神经元焦亡。在体外,miR-212-3p 通过抑制 NLRP3/Caspase-1 提高了神经元的活力并抑制了细胞焦亡。总体而言,miR-212-3p 抑制 SP1 表达以阻断 BACE1 诱导的 NLRP3/Caspase-1 激活,从而减轻 AD 大鼠的神经炎症。miR-212-3p 过表达与改善 AD 大鼠的学习和记忆能力有关,并减少与神经炎症减弱有关的神经元焦亡。在体外,miR-212-3p 通过抑制 NLRP3/Caspase-1 提高了神经元的活力并抑制了细胞焦亡。总体而言,miR-212-3p 抑制 SP1 表达以阻断 BACE1 诱导的 NLRP3/Caspase-1 激活,从而减轻 AD 大鼠的神经炎症。
更新日期:2022-02-12
down
wechat
bug